01 1National Cancer Institute
01 1PSEUDOMONAS EXOTOXIN (RECOMBINANT, NLYSPE38) CONJUGATED MURINE MAB (B3) TO B3 ANTIGEN AND RITUXIMAB [CHIMERIC MOAB (C2B8) (IDEC) TO CD20]
01 1U.S.A
01 1Inactive
01 1Blank
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18615
Submission : 1993-03-22
Status : Inactive
Type : II
27
PharmaCompass offers a list of Bevacizumab+Rituximab API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bevacizumab+Rituximab manufacturer or Bevacizumab+Rituximab supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bevacizumab+Rituximab manufacturer or Bevacizumab+Rituximab supplier.
PharmaCompass also assists you with knowing the Bevacizumab+Rituximab API Price utilized in the formulation of products. Bevacizumab+Rituximab API Price is not always fixed or binding as the Bevacizumab+Rituximab Price is obtained through a variety of data sources. The Bevacizumab+Rituximab Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bevacizumab+Rituximab manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bevacizumab+Rituximab, including repackagers and relabelers. The FDA regulates Bevacizumab+Rituximab manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bevacizumab+Rituximab API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bevacizumab+Rituximab supplier is an individual or a company that provides Bevacizumab+Rituximab active pharmaceutical ingredient (API) or Bevacizumab+Rituximab finished formulations upon request. The Bevacizumab+Rituximab suppliers may include Bevacizumab+Rituximab API manufacturers, exporters, distributors and traders.
click here to find a list of Bevacizumab+Rituximab suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bevacizumab+Rituximab DMF (Drug Master File) is a document detailing the whole manufacturing process of Bevacizumab+Rituximab active pharmaceutical ingredient (API) in detail. Different forms of Bevacizumab+Rituximab DMFs exist exist since differing nations have different regulations, such as Bevacizumab+Rituximab USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bevacizumab+Rituximab DMF submitted to regulatory agencies in the US is known as a USDMF. Bevacizumab+Rituximab USDMF includes data on Bevacizumab+Rituximab's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bevacizumab+Rituximab USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bevacizumab+Rituximab suppliers with USDMF on PharmaCompass.
We have 1 companies offering Bevacizumab+Rituximab
Get in contact with the supplier of your choice:
